ArticleFrontiers in nutrition2026
The role of nutritional risk in inflammatory bowel disease: a serial mediation model through fecal calprotectin and depression leading to impaired quality of life.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with inflammatory bowel disease (IBD) frequently face high nutritional risk, persistent intestinal inflammation, and a high prevalence of comorbid depression. Dysregulation of the gut-brain axis is hypothesized to mediate the association between nutritional status and quality of life (QOL). However, the serial mediating roles of fecal calprotectin (FC) and depression in this pathway remain unclear. This study aimed to examine this serial mediation and provide evidence for developing integrated care models centered on nutritional management to modulate inflammation, manage psychological complications, and improve patient outcomes. Methods: This cross-sectional study enrolled 327 IBD patients from four tertiary hospitals in Southwest China. Nutritional risk, depressive symptoms, and QOL were assessed using the Nutritional Risk Screening 2002 (NRS2002), the Patient Health Questionnaire-9 (PHQ-9), and the Inflammatory Bowel Disease Questionnaire (IBDQ), respectively. FC levels were measured using an enzyme-linked immunosorbent assay (ELISA). The serial mediating effects were examined using Model 6 of the SPSS PROCESS macro with 5,000 bootstrap resamples. Results: Nutritional risk was positively correlated with FC ( Conclusion: Nutritional risk is associated with impaired QOL in IBD patients both directly and indirectly through a sequential pathway involving intestinal inflammation (FC) and depression. These findings suggest a shift in clinical practice toward an integrated care model anchored in proactive nutritional management, coupled with concurrent monitoring of inflammation and screening for depression. This model presents a targeted strategy for modulating inflammation, managing comorbidities, and ultimately improving symptoms and QOL in IBD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.